CN100484957C - 胸腺素β4衍生物及其应用 - Google Patents
胸腺素β4衍生物及其应用 Download PDFInfo
- Publication number
- CN100484957C CN100484957C CNB2005101032937A CN200510103293A CN100484957C CN 100484957 C CN100484957 C CN 100484957C CN B2005101032937 A CNB2005101032937 A CN B2005101032937A CN 200510103293 A CN200510103293 A CN 200510103293A CN 100484957 C CN100484957 C CN 100484957C
- Authority
- CN
- China
- Prior art keywords
- gly
- lys
- rat
- glu
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (3)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101032937A CN100484957C (zh) | 2005-09-23 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
EP06761426A EP1908779B1 (en) | 2005-07-15 | 2006-07-14 | Thymosin beta 4 derivatives and use thereof |
KR1020087003496A KR100984635B1 (ko) | 2005-07-15 | 2006-07-14 | 티모신 β4 유도체 및 이의 용도 |
JP2008520699A JP5180074B2 (ja) | 2005-07-15 | 2006-07-14 | サイモシンβ4誘導体及びその使用方法 |
PL06761426T PL1908779T3 (pl) | 2005-07-15 | 2006-07-14 | Pochodne tymozyny beta 4 i ich zastosowanie |
PCT/CN2006/001679 WO2007009359A1 (fr) | 2005-07-15 | 2006-07-14 | Derives de thymosine beta 4 et utilisation |
US11/995,817 US7816321B2 (en) | 2005-07-15 | 2006-07-14 | Thymosin β4 derivatives and use thereof |
CN200680025339A CN100582121C (zh) | 2005-07-15 | 2006-07-14 | 胸腺素β4衍生物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101032937A CN100484957C (zh) | 2005-09-23 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1935838A CN1935838A (zh) | 2007-03-28 |
CN100484957C true CN100484957C (zh) | 2009-05-06 |
Family
ID=37953602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101032937A Active CN100484957C (zh) | 2005-07-15 | 2005-09-23 | 胸腺素β4衍生物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100484957C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101910908B1 (ko) * | 2017-06-14 | 2018-10-24 | (주)휴온스 | Gly-Tβ4 (Gly-티모신β4)을 함유하는 안구건조증 치료용 약학적 조성물 |
KR20200081402A (ko) * | 2017-11-24 | 2020-07-07 | 주식회사 지트리비앤티 | 티모신 베타 4 또는 이의 유도체를 유효성분으로 포함하는 술잔세포 증식 또는 뮤신 분비 촉진용 조성물 |
CN108498788A (zh) * | 2018-06-26 | 2018-09-07 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4的用途 |
KR102140531B1 (ko) * | 2018-08-07 | 2020-08-04 | (주)휴온스 | Gly-Tβ4의 제조방법 |
CN108853483B (zh) * | 2018-08-10 | 2022-03-15 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途 |
CN110215513B (zh) * | 2018-11-15 | 2022-02-22 | 北京诺思兰德生物技术股份有限公司 | 经修饰的胸腺素β4在治疗放射性肠炎方面的用途 |
-
2005
- 2005-09-23 CN CNB2005101032937A patent/CN100484957C/zh active Active
Non-Patent Citations (4)
Title |
---|
. GenBank号:AAP36809. 2003 |
. GenBank号:AAQ55552. 2004 |
. GenBank号:AAP36809. 2003 * |
. GenBank号:AAQ55552. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
CN1935838A (zh) | 2007-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100582121C (zh) | 胸腺素β4衍生物及其应用 | |
CN102883736B (zh) | 用于促进血管生成的肽及其用途 | |
CN100484957C (zh) | 胸腺素β4衍生物及其应用 | |
US20110117195A1 (en) | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers | |
CN113683679B (zh) | 一种重组i型人源化胶原蛋白c1l6t及其制备方法和用途 | |
CN1978466B (zh) | 转导肽-人脑源性神经营养因子融合蛋白及其应用 | |
CN102884073B (zh) | 用于促进血管生成的肽及其用途 | |
CN1896096A (zh) | 基因工程方法生产的高活性胸腺素β4衍生物 | |
CN100372572C (zh) | 携带人胸腺素β4基因的重组质粒 | |
CN100535005C (zh) | 长链人胰岛素样生长因子(lr3igf-1)及其制备和应用方法 | |
CN117510619B (zh) | 一种创新空间结构的重组ⅲ型人源化胶原蛋白微球及其设计、制备工艺和应用 | |
CN103031268B (zh) | OGP-rhLeptin融合蛋白转基因工程菌株 | |
CN101899116B (zh) | 无创性高穿透性表皮生长因子及其应用 | |
CN102397534B (zh) | 胰岛素在制备促进颌骨组织愈合的药物中的用途 | |
CN101921820A (zh) | 具有活性重组肿瘤特异性凋亡因子的制备方法及其制品的应用 | |
CN102964452B (zh) | 用于治骨质疏松症和肥胖的msCT-rhLeptin融合蛋白及编码该融合蛋白的核酸 | |
CN102964451B (zh) | 用于治疗骨质疏松症和止痛的msCT-CTx融合蛋白及编码该融合蛋白的核酸 | |
CN103012597B (zh) | 用于治疗骨质疏松症和止痛的OGP-CTx融合蛋白及编码该融合蛋白的核酸 | |
CN102965325B (zh) | msCT-CTx融合蛋白转基因工程菌株 | |
CN102675449B (zh) | 缺失型人角质细胞生长因子-ⅰ二硫键变构体及其用途 | |
CN101306193A (zh) | 人神经突起生长素在制备创伤愈合药物中的应用 | |
CN103013901B (zh) | OGP-CTx融合蛋白转基因工程菌株 | |
JP2003113095A (ja) | Dna合成促進剤 | |
CN103012598A (zh) | 用于治骨质疏松症和肥胖的OGP-rhLeptin融合蛋白及编码该融合蛋白的核酸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Thymosin beta4 derivative and itsuse Effective date of registration: 20100415 Granted publication date: 20090506 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Northland Biotechnology Co., Ltd. Registration number: 2010990000737 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20110419 Granted publication date: 20090506 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Northland Biotechnology Co., Ltd. Registration number: 2010990000737 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070328 Assignee: Beijing North Rand Medical Technology Co., Ltd. Assignor: Beijing Northland Biotechnology Co., Ltd. Contract record no.: 2012990000805 Denomination of invention: Thymosin beta4 derivative and itsuse Granted publication date: 20090506 License type: Exclusive License Record date: 20121031 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |